Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Chamberlin

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 28, 1999
Blockers of human T cell Kv1.3 potassium channels using de novo ligand design and solid-phase parallel combinatorial chemistryA Lew, A R Chamberlin
Methods in Molecular Biology (Clifton, N.J.)|October 15, 1998
Protein engineering with nonstandard amino acidsL E Steward, A R Chamberlin
Bioorganic & Medicinal Chemistry|November 14, 1997
Inhibition of the Ser-Thr phosphatases PP1 and PP2A by naturally occurring toxinsJ E Sheppeck, C M Gauss, A R Chamberlin
Methods in Enzymology|October 21, 1998
Design and synthesis of conformationally constrained inhibitors of high-affinity, sodium-dependent glutamate transportersA R Chamberlin, H P Koch, R J Bridges
Current Pharmaceutical Design|April 24, 1999
A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous systemR J Bridges, M P Kavanaugh, A R Chamberlin
Molecular Pharmacology|May 29, 1999
Nontransportable inhibitors attenuate reversal of glutamate uptake in synaptosomes following a metabolic insultH P Koch, A R Chamberlin, R J Bridges
International Journal of Peptide Research and Therapeutics|June 19, 2012
Improving the Fmoc Solid Phase Synthesis of the Cyclic Hexapeptide Complement C5a Antagonist, PMX205R C Delisle Milton, S C Milton, A R Chamberlin
Nature|April 9, 1992
Ribosome-mediated incorporation of a non-standard amino acid into a peptide through expansion of the genetic codeJ D Bain, C Switzer, A R Chamberlin, et al.
European Journal of Pharmacology|October 14, 1994
Pharmacological dissociation of glutamatergic metabotropic signal transduction pathways in cortical astrocytesS Miller, R J Bridges, A R Chamberlin, et al.
Brain Research|November 14, 1983
Synthesis of [3H]2-amino-4-phosphonobutyric acid and characterization of its binding to rat brain membranes: a selective ligand for the chloride/calcium-dependent class of L-glutamate binding sitesD T Monaghan, M C McMills, A R Chamberlin, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|December 28, 1999
Blockers of human T cell Kv1.3 potassium channels using de novo ligand design and solid-phase parallel combinatorial chemistryA Lew, A R Chamberlin
Methods in Molecular Biology (Clifton, N.J.)|October 15, 1998
Protein engineering with nonstandard amino acidsL E Steward, A R Chamberlin
Bioorganic & Medicinal Chemistry|November 14, 1997
Inhibition of the Ser-Thr phosphatases PP1 and PP2A by naturally occurring toxinsJ E Sheppeck, C M Gauss, A R Chamberlin
Methods in Enzymology|October 21, 1998
Design and synthesis of conformationally constrained inhibitors of high-affinity, sodium-dependent glutamate transportersA R Chamberlin, H P Koch, R J Bridges
Current Pharmaceutical Design|April 24, 1999
A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous systemR J Bridges, M P Kavanaugh, A R Chamberlin
Molecular Pharmacology|May 29, 1999
Nontransportable inhibitors attenuate reversal of glutamate uptake in synaptosomes following a metabolic insultH P Koch, A R Chamberlin, R J Bridges
International Journal of Peptide Research and Therapeutics|June 19, 2012
Improving the Fmoc Solid Phase Synthesis of the Cyclic Hexapeptide Complement C5a Antagonist, PMX205R C Delisle Milton, S C Milton, A R Chamberlin
Nature|April 9, 1992
Ribosome-mediated incorporation of a non-standard amino acid into a peptide through expansion of the genetic codeJ D Bain, C Switzer, A R Chamberlin, et al.
European Journal of Pharmacology|October 14, 1994
Pharmacological dissociation of glutamatergic metabotropic signal transduction pathways in cortical astrocytesS Miller, R J Bridges, A R Chamberlin, et al.
Brain Research|November 14, 1983
Synthesis of [3H]2-amino-4-phosphonobutyric acid and characterization of its binding to rat brain membranes: a selective ligand for the chloride/calcium-dependent class of L-glutamate binding sitesD T Monaghan, M C McMills, A R Chamberlin, et al.
Pageof 3